ArticleBMC research notes2025
Dataset of obesity in relation to female-specific cancers in middle eastern countries, 1990 to 2016.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesUnderstanding the relationship between obesity and female-specific cancers (FSCs) is crucial for public health planning and policy development. The current data paper presented a dataset that includes obesity prevalence and incidence rates of breast, ovarian, cervical, and uterine cancers among women in Middle Eastern countries. This dataset could be used for time-trend analysis and different forecasting models. Moreover, exploring the relationship between obesity and FSCs is important to develop preventive healthcare services, especially among developing countries. DATA DESCRIPTION: The dataset comprises official statistics obtained from reputable sources including the world bank and global burden of disease (GBD) database. The data include a total of 405 observations across 15 middle-eastern countries, from 1990 to 2016. Key variables are obesity prevalence and incidence rate of four major cancers in women including breast cancer, ovarian cancer, cervical cancer, and uterine cancer. This panel data is mainly prepared to investigate the temporal relationship between obesity prevalence and FSC incidence rates, and also performing Counterfactual analysis. Moreover, this data could be utilized for advanced machine learning techniques to estimate future shifts in trend and patterns over time.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.